Back to company

Pharma IT ApS: Financial statements 2020

CVR: 37320595

Pharma IT ApS (CVR 37320595) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 80,389,192 and a net result of DKK 14,121,814 compared with DKK 4,014,705 the year before. That is an increase of 98.6% compared with the year before. Equity amounted to DKK 14,287,316. The solvency ratio was 33.6%. The company had 53 employees in the financial year.

Gross Profit
80,389,192 kr.
Profit/Loss
14,121,814 kr.
Equity
14,287,316 kr.
Total Assets
42,559,006 kr.
Employees
53

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-80.4 mio.14.1 mio.14.3 mio.53
2019-40.5 mio.4 mio.5.4 mio.-
2018-25.2 mio.2.4 mio.2.7 mio.-
2017-12.5 mio.735 t.1.7 mio.-
2016-5 mio.854 t.954 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Pharma IT ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Pharma IT ApS: The 2019 annual report is outMay 14, 2020

Pharma IT ApS has published its annual report for 2019. Gross profit came to DKK 40,473,352, and the net result was DKK 4,014,705.

Peter-Emil Iversen joins Pharma IT ApS as directorApr 7, 2020

As of April 7, 2020, Peter-Emil Iversen is registered as director of Pharma IT ApS.

Ea Marie Berg Holst joins Pharma IT ApS as directorApr 7, 2020

As of April 7, 2020, Ea Marie Berg Holst is registered as director of Pharma IT ApS.

About Pharma IT ApS

Pharma IT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jakob Juul Rasmussen, Søren Winkel and Peter-Emil Iversen. The company is owned by ProductLife ApS. The company has 31 employees. In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. Equity amounted to DKK 47,568,805.